IL13 and Alzheimer disease: Our findings support emerging evidence for the role of NOD2 in regulating type 2 adaptive immune responses at the skin barrier surface in humans and highlight a novel endogenous mechanism modulating pathogenic IL-13 that may open an avenue for future translational research in AD.